The introduction of Qdenga has brought renewed attention to efforts aimed at controlling Dengue Fever, a mosquito-borne illness that continues to challenge public health systems in many countries. While the vaccine offers a valuable layer of protection, health specialists caution that it cannot completely stop the spread of dengue and should be used alongside existing preventive measures.

A Helpful Addition to Dengue Control

Qdenga, developed by Takeda Pharmaceutical Company, is designed to provide immunity against the four major dengue virus types. Administered in two doses, the vaccine aims to lower the likelihood of infection and reduce complications in those who contract the disease. Experts believe that introducing the vaccine in regions where dengue cases are frequent could help decrease hospitalisations and ease the burden on healthcare services.

Dengue outbreaks often intensify during rainy seasons when stagnant water becomes a breeding ground for mosquitoes. In urban areas with dense populations, the virus can spread quickly, making preventive measures essential. The availability of a vaccine is therefore viewed as an important step forward in limiting the severity of outbreaks.

Vaccine Alone Cannot Stop Transmission

Despite its benefits, specialists stress that Qdenga is not a complete safeguard. People who receive the vaccine may still develop dengue, although the illness is expected to be milder in many cases. Protection levels may also differ depending on age, immunity, and circulating virus strains.

Because dengue spreads through infected mosquitoes, vaccination alone cannot eliminate the disease. If mosquito populations remain uncontrolled, the virus can continue to circulate within communities.

Continued Focus on Prevention

Public health experts emphasize that eliminating mosquito breeding sites remains the most effective way to control dengue. Measures such as removing stagnant water, maintaining clean surroundings, and improving sanitation are essential. Community awareness campaigns also help encourage individuals to take precautions at home and in public spaces.

Combined Strategy for Long-Term Control

The introduction of Qdenga represents progress in dengue prevention, but experts recommend a comprehensive approach. Vaccination, along with strong surveillance systems, early diagnosis, and vector control, can work together to reduce the impact of outbreaks.

While the vaccine offers hope in reducing severe illness, long-term success in tackling dengue will depend on sustained preventive efforts. A balanced strategy combining immunisation and mosquito control is likely to provide the most effective protection against the disease.